Cite

    Qiang Wang and Keping Yang. “Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention.” Medicine, vol. 100, no. 15, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100142325477.0x00003c